Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients: A 1-year Observational Study
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- 19 Dec 2016 Status changed from recruiting to completed.
- 11 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 04 Jul 2015 New trial record